title: Comments on the value International Prognostic Score (IPS), stage IV and age over 45 years, for the outcome of advanced Hodgkin lymphoma in chemotherapy containing adriamycin. The experience of the Spanish Hodgkin Lymphoma Study Group.
authors.affiliation: Department of Internal Medicine, Hospital Quiron San Camilo, Madrid, Spain.
authors.forename: Pablo
authors.initials: P
authors.lastname: Guisado-Vasco
authors.affiliation: Department of Haematology, MD Anderson Cancer Center, Madrid, Spain.
authors.forename: Carlos
authors.initials: C
authors.lastname: Montalban
authors.affiliation: Department of Pathology, MD Anderson Cancer Center, Madrid, Spain.
authors.forename: Juan F
authors.initials: JF
authors.lastname: García
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols; D004317:Doxorubicin; D006689:Hodgkin Disease; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D014747:Vinblastine; D014750:Vincristine
chemical_list: D014750:Vincristine; D014747:Vinblastine; D004317:Doxorubicin
keywords: Hodgkin lymphoma; clinical research; prognostic factors